To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

NCT06168383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Steatohepatitis (NASH)

Interventions

DRUG: HSK31679 80mg
DRUG: HSK31679 160mg
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.